Friederike Kanefendt

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Mycobacterium Tuberculosis

Top Venues

Clinical pharmacology and therapeutics

Clinical and translational science

British journal of clinical pharmacology

European journal of drug metabolism and pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Huijun Chen, Kensei Hashizume, Friederike Kanefendt, Christine Brase, Sebastian Schmitz, Tianxing Liu
Pharmacokinetics, pharmacodynamics, and safety of asundexian in healthy Chinese and Japanese volunteers, and comparison with Caucasian data. Clinical and translational science 17 (8) (2024)
Friederike Kanefendt, André Dallmann, Huijun Chen, Klaus Francke, Tianxing Liu, Christine Brase, Sebastian Frechen, Marcus-Hillert Schultze-Mosgau
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling. Clinical pharmacology and therapeutics 115 (5) (2024)
Huijun Chen, Kensei Hashizume, Friederike Kanefendt, Christine Brase, Sebastian Schmitz, Tianxing Liu
Pharmacokinetics, pharmacodynamics, and safety of asundexian in healthy Chinese and Japanese volunteers, and comparison with Caucasian data. Clinical and translational science 17 (8) (2024)
Friederike Kanefendt, André Dallmann, Huijun Chen, Klaus Francke, Tianxing Liu, Christine Brase, Sebastian Frechen, Marcus-Hillert Schultze-Mosgau
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling. Clinical pharmacology and therapeutics 115 (5) (2024)
Friederike Kanefendt, André Dallmann, Huijun Chen, Klaus Francke, Tianxing Liu, Christine Brase, Sebastian Frechen, Marcus-Hillert Schultze-Mosgau
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling. Clinical pharmacology and therapeutics (2023)
Friederike Kanefendt, Christine Brase, Natalia Jungmann, Robert Fricke, Anna Engelen, Sebastian Schmitz
Pharmacokinetics of asundexian with combined CYP3A and P-gp inhibitors and an inducer: Target in vitro and in vivo studies. British journal of clinical pharmacology (2023)
Friederike Kanefendt, André Dallmann, Huijun Chen, Klaus Francke, Tianxing Liu, Christine Brase, Sebastian Frechen, Marcus-Hillert Schultze-Mosgau
Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from two Clinical DDI Studies and PBPK Modeling. Clinical pharmacology and therapeutics (2023)
Isabel Piel, Anna Engelen, Dieter Lang, Simone I Schulz, Michael Gerisch, Christine Brase, Wiebke Janssen, Lukas Fiebig, Stefan Heitmeier, Friederike Kanefendt
Metabolism and Disposition of the Novel Oral Factor XIa Inhibitor Asundexian in Rats and in Humans. European journal of drug metabolism and pharmacokinetics (2023)